9-133332733-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_006753.6(SURF6):c.421G>A(p.Ala141Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,611,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006753.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SURF6 | NM_006753.6 | c.421G>A | p.Ala141Thr | missense_variant | 4/5 | ENST00000372022.6 | NP_006744.2 | |
SURF6 | NM_001278942.2 | c.420G>A | p.Pro140= | synonymous_variant | 4/5 | NP_001265871.1 | ||
SURF6 | NR_103874.2 | n.424G>A | non_coding_transcript_exon_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SURF6 | ENST00000372022.6 | c.421G>A | p.Ala141Thr | missense_variant | 4/5 | 1 | NM_006753.6 | ENSP00000361092 | P1 | |
SURF6 | ENST00000468290.1 | n.207G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000731 AC: 18AN: 246158Hom.: 0 AF XY: 0.0000671 AC XY: 9AN XY: 134218
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1459082Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 726040
GnomAD4 genome AF: 0.000204 AC: 31AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74452
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at